Furthermore, insulin use was associated with better mortality outcomes on time-dependent 42-day survival analysis compared to both patients without DM/hyperglycemia (p = 0.04) and those with DM/hyperglycemia not receiving insulin (p = 0.03, Figure 1c). The gene discussed is INS; the disease is Hyperglycemia.